Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07209566 · ClinicalTrials.gov registry record · NA
A Research Study Exploring How Musculoskeletal Function and the Autonomic Nervous System Relate to Visceral Pain in Women With and Without Dysmenorrhea (Painful Periods).
A NA study of Menstrual Pain and Visceral Pain, sponsored by Azusa Pacific University.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT07209566: Recruiting NA study of Menstrual Pain and Visceral Pain, sponsored by Azusa Pacific University.
NCT07209566 is a NA study of Menstrual Pain and Visceral Pain that is actively recruiting participants, run by Azusa Pacific University. The registered enrollment target is 60 participants, below the 70-participant average among 3 other Menstrual Pain trials with a reported enrollment target (14% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07209566, a NA study of Menstrual Pain and Visceral Pain, is actively recruiting participants, sponsored by Azusa Pacific University.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this clinical trial is to determine if women with dysmenorrhea demonstrate an increased musculoskeletal and autonomic nervous system response to a painful visceral stimulus compared to controls. A secondary aim is to determine if interoceptive awareness moderates this relationship. The designed methodology aims to elucidate the intricate connections between the interoceptive and musculoskeletal systems in pain perception among female participants, providing valuable insights into the underlying mechanisms of interoceptive pain and functional musculoskeletal changes.
Primary Outcome
The change in hip range of motion from baseline to after a visceral pain stimulus is a primary outcome measure of this study. This measurement will be compared between groups to determine if those with dysmenorrhea react to a painful stimulus differently compared to those without dysmenorrhea.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Visceral Pain Stimulus
Study Locations (1)
California
- Azusa Pacific University - Azusa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2025-08-01 |
| Est. Completion | 2027-04-01 |
| Phase | NA |
What NCT07209566 shows while recruiting
NCT07209566 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 70-participant average among 3 other Menstrual Pain trials with a reported enrollment target (14% lower).
The record links to 4 conditions, with Menstrual Pain appearing as the primary indexed condition, and to 1 intervention - of which Visceral Pain Stimulus is the first listed.
NCT07209566 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT07209566 about?
NCT07209566 is a clinical study titled "A Research Study Exploring How Musculoskeletal Function and the Autonomic Nervous System Relate to Visceral Pain in Women With and Without Dysmenorrhea (Painful Periods).". The purpose of this clinical trial is to determine if women with dysmenorrhea demonstrate an increased musculoskeletal and autonomic nervous system response to a painful visceral stimulus compared to controls. A secondary aim is to determine if interoceptive awareness moderates this relationship. Th...
What is the current status of trial NCT07209566?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-08-01. Estimated completion is 2027-04-01.
What conditions does trial NCT07209566 study?
This clinical trial studies the following conditions: Menstrual Pain, Visceral Pain, Dysmenorrhea, Dysmenorrhea Primary.
What interventions are being tested in trial NCT07209566?
The interventions under investigation include: Visceral Pain Stimulus (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07209566?
This trial is sponsored by Azusa Pacific University, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07209566 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Menstrual Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
An Open-Label Study to Evaluate the Effect of Elix Cycle Balance & Elix Daily Harmony on Fibroid-related Symptoms
RECRUITING · NA
-
Study to Evaluate the Efficacy of Elix's Cycle Balance and Its Impact on PMS and Menstrual Symptoms
COMPLETED · NA
-
An Investigation Into the Efficacy of a Botanical Supplement to Provide Period Relief
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI